Fernandez Lynch H, Sarpatwari A, Vonderheide RH, Zettler PJ - Journal of Clinical Oncology
Oncologists will be at the forefront of Right to Try requests given the strong demand for pre-approval access to cancer therapies, and physicians face difficult gatekeeping obligations in managing patient expectations while navigating a law that removes FDA and IRB oversight from the access process.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Daval CJR, Kesselheim AS - STAT
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine